0001144204-19-025339.txt : 20190510 0001144204-19-025339.hdr.sgml : 20190510 20190510171546 ACCESSION NUMBER: 0001144204-19-025339 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190510 DATE AS OF CHANGE: 20190510 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Armata Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-44887 FILM NUMBER: 19815987 BUSINESS ADDRESS: STREET 1: 3579 VALLEY CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 804-827-2524 MAIL ADDRESS: STREET 1: 3579 VALLEY CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: AmpliPhi Biosciences Corp DATE OF NAME CHANGE: 20130222 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DELTA DENTAL OF CALIFORNIA CENTRAL INDEX KEY: 0001775168 IRS NUMBER: 941461312 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 560 MISSION STREET, SUITE 1300 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-972-8300 MAIL ADDRESS: STREET 1: 560 MISSION STREET, SUITE 1300 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 SC 13G 1 tv521242_sc13g.htm SCHEDULE 13G

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. )

Armata Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

04216R 102

(CUSIP Number)

May 9, 2019

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨		Rule 13d-1(b)
x		Rule 13d-1(c)
¨		Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 04216R 102

1.	Names of Reporting Persons Delta Dental of California
2.	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a)	¨
	(b)	¨
3.	SEC Use Only
4.	Citizenship or Place of Organization California

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With:

Sole Voting Power

990,643

Shared Voting Power

990,643

Sole Dispositive Power

990,643

Shared Dispositive Power

990,643

9.		Aggregate Amount Beneficially Owned by Each Reporting Person 990,643
10.		Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.		Percent of Class Represented by Amount in Row (9) 9.95%
12.		Type of Reporting Person (See Instructions) CO, IC

Item 1.
	(a)	Name of Issuer
		Armata Pharmaceuticals, Inc.
	(b)	Address of Issuer's Principal Executive Offices
		4503 Glencoe Avenue Marina del Rey, California 90292

Item 2.
	(a)	Name of Person Filing
		Delta Dental of California

	(b)	Address of Principal Business Office or, if none, Residence
		The business address for the reporting person is: 560 Mission Street, Suite 1300 San Francisco, California 94105
	(c)	Citizenship
		Delta Dental of California is a corporation organized under the laws of the state of California.
	(d)	Title of Class of Securities
		Common Stock, $0.01 par value
	(e)	CUSIP No.
		04216R 102
Item 3.		If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:
		Not Applicable
Item 4.		Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)

Amount beneficially owned: 990,643 shares.

(b)

Percent of class: 9.95%.

(c)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote 990,643 shares.

(ii)

Shared power to vote or to direct the vote 990,643 shares.

(iii)

Sole power to dispose or to direct the disposition of 990,643 shares.

(iv)

Shared power to dispose or to direct the disposition of 990,643 shares.

Item 5.	Ownership of Five Percent or Less of a Class
	Not Applicable

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.
	Not Applicable

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
	Not Applicable

Item 8.	Identification and Classification of Members of the Group
	Not Applicable

Item 9.	Notice of Dissolution of Group
	Not Applicable

Item 10.	Certification
	By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Sec. 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: May 10, 2019

	Delta Dental of California


	By:		/s/ Michael G. Hankinson
			Name: Michael G. Hankinson
			Title: Executive VP and Chief Legal Officer